Understanding the Natural History and the Effects of Current Therapeutic Strategies on Urea Cycle Disorders: Insights from the UCD Spanish Registry
(This article belongs to the Special Issue Nutritional Treatment and Screening for Inherited Metabolic Diseases).
| Autores: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2025 |
| País: | España |
| Institución: | Consejo Superior de Investigaciones Científicas (CSIC) |
| Repositorio: | DIGITAL.CSIC. Repositorio Institucional del CSIC |
| OAI Identifier: | oai:digital.csic.es:10261/385752 |
| Acceso en línea: | http://hdl.handle.net/10261/385752 |
| Access Level: | acceso abierto |
| Palabra clave: | Urea cycle disorders (UCDs) Arginase 1 (ARG1) Argininosuccinate lyase (ASL) Argininosuccinate synthetase (ASS1) Carbonic anhydrase VA (CA-VA) Citrin Carbamoylphosphate synthetase (CPS1) Hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) N-acetylglutamate synthase (NAGS) Ornithine/citrulline antiporter (ORNT) Ornithine transcarbamylase (OTC) |
| Sumario: | (This article belongs to the Special Issue Nutritional Treatment and Screening for Inherited Metabolic Diseases). |
|---|